Track Alpa Laboratories Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 1.11 %
Low
65.9
High
72.5
1 Month returns: 0.89 %
Low
64.3
High
79.0
1 Year returns: -29.10 %
Low
46.0
High
101.0
3 Year CAGR: -3.63 %
Low
46.0
High
144.5
5 Year CAGR: 4.39 %
Low
46.0
High
144.5
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Alpa Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Alpa Laboratories Ltd. Shareholding Pattern
Quarterly breakdown of Alpa Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Alpa Laboratories Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Alpa Laboratories Ltd.?
The current share price of Alpa Laboratories Ltd. is ₹ 68.10 as of 7 Aug 2026.
What is the market capitalisation of Alpa Laboratories Ltd.?
The market capitalisation of Alpa Laboratories Ltd. stands at ₹ 143.29 Cr.
What is the PE ratio of Alpa Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Alpa Laboratories Ltd. is 9.55 as of the latest trailing twelve months data.
What is the ROE and ROCE of Alpa Laboratories Ltd.?
Alpa Laboratories Ltd. has a Return on Equity (ROE) of 8.39% and a Return on Capital Employed (ROCE) of 0.67% as per the latest financial reports.
What is the 52-week high and low of Alpa Laboratories Ltd.?
The 52-week high of Alpa Laboratories Ltd. is - and the 52-week low is -.
What is the dividend yield of Alpa Laboratories Ltd.?
The dividend yield of Alpa Laboratories Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Alpa Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 0.35%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 41.54% of Alpa Laboratories Ltd. shares.
What sector does Alpa Laboratories Ltd. belong to?
Alpa Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Alpa Laboratories Ltd.?
The beta of Alpa Laboratories Ltd. is 0.99, indicating its price volatility relative to the broader market. Over the past 1 year, Alpa Laboratories Ltd. has delivered an absolute return of -34.52%.
What is the RSI of Alpa Laboratories Ltd.?
The 14-day Relative Strength Index (RSI) of Alpa Laboratories Ltd. is 50.30, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Name
Month
Transaction
Holding % pre transaction
Average price
Qty.
Transaction value
Paresh Chawla
Promoter
June-2022
Off Market (Acquisition)
14th Jun 2022
15.92 %
₹ 0.00
3.37 lac
-
SHITUL SHAH
Promoter
March-2022
Inter-se Transfer (Acquisition)
5th Mar 2022
2.60 %
₹ 0.00
3.79 lac
₹ 0.00
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
56.66
56.66
56.66
56.66
56.66
56.66
56.66
56.66
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.19
57.19
Indian Promoter
56.66
56.66
56.66
56.66
56.66
56.66
56.66
56.66
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.29
57.19
57.19
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
-
-
-
-
-
-
0.00
0.14
0.56
0.21
0.14
0.00
0.01
0.01
0.11
0.95
0.50
0.36
0.74
0.35
0.40
0.36
0.35
0.36
0.38
0.42
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
0.05
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.56
0.21
0.14
0.00
0.00
0.00
0.11
0.95
0.50
0.36
0.74
0.35
0.40
0.36
0.35
0.36
0.38
0.35
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.07
Non-Institution
43.34
43.34
43.34
43.34
43.34
43.34
43.34
43.20
42.15
42.50
42.56
42.71
42.69
42.69
42.60
41.75
42.20
42.35
41.96
42.35
42.31
42.34
42.35
42.35
42.43
42.39
Bodies Corporate
1.63
1.57
1.46
1.47
1.59
1.44
1.50
1.57
1.52
1.43
1.48
1.50
1.41
1.40
1.66
1.50
1.49
1.50
1.61
1.16
0.54
0.68
0.68
0.68
0.79
0.85
Others (incl. Retail)
No. of shareholders
41.71
12,130
41.77
12,633
41.88
13,148
41.87
13,691
41.75
13,176
41.90
15,486
41.84
15,524
41.63
16,044
40.63
18,707
41.07
18,734
41.08
18,778
41.21
19,027
41.28
19,078
41.29
18,686
40.94
18,504
40.25
18,619
40.71
18,627
40.85
18,049
40.35
18,802
41.19
19,144
41.77
18,815
41.66
18,798
41.67
18,492
41.67
18,185
41.64
17,852
41.54
17,592
Stock Analysis
Fundamental analysis overview of Alpa Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
PE TTM of 9.55 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -68.78%
What is P/E Ratio?
Median: 30.59
Value 9.55
0.33286.35
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Weak price momentum
Price Momentum score of 29.9 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term
What is Price Momentum score?
29.9 / 100
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 41.1 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
41.1 / 100
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.155064.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Company Profile
Overview of Alpa Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterina...